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Abstract
Background: Household decision-makers decide about service use based largely on the costs and
perceived benefits of health interventions. Very often this leads to different decisions than those
imagined by health planners, resulting in under-utilisation of public services like immunisation. In
the case of Lasbela district in the south of Pakistan, only one in every ten children is immunised
despite free immunisation offers by government health services.
Methods/design:  In 32 communities representative of Lasbela district, 3344 households
participated in a baseline survey on early child health. In the 18 randomly selected intervention
communities, we will stimulate discussions on the household cost-benefit equation, as measured in
the baseline. The reference (control) communities will also participate in the three annual follow-
up surveys, feedback of the general survey results and the usual health promotion activities relating
to immunisation, but without focussed discussion on the household cost-benefit equations.
Discussion: This project proposes knowledge translation as a two-way communication that can
be augmented by local and international evidence. We will document cultural and contextual
barriers to immunisation in the context of household cost-benefit equations. The project makes
this information accessible to health managers, and reciprocally, makes information on
immunisation effects and side effects available to communities. We will measure the impact of this
two-way knowledge translation on immunisation uptake.
Background
Despite billions of dollars spent on childhood immunisa-
tion, some countries have never reached universal child-
hood immunisation (UCI), and many more have been
unable to sustain it. An estimated 1.5 million deaths
under 5 years of age can be prevented by vaccination each
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year, measles making up 37% H. influenzae b-related dis-
ease 30%, and pertussis 19%[1]. In many countries, there
is dramatic underutilisation of the offer of free immunisa-
tion. One reason for this is a difference between under-
standing of the costs and benefits of vaccination in
international public health circles, and what primary deci-
sion-makers for children know about immunisation and
its costs.
There is a gap between the way public health specialists
understand immunisation benefits, and the cost-benefit
equations that household decision-makers apply to their
children's immunisation. In settings like Pakistan, where
an expanded program of immunisation is offered free of
charge, uptake is largely determined by access to services
and the attendant cost-benefit assessments by parents and
caregivers. These assessments could be influenced by
access to knowledge and conditioned by gender and social
inequalities.
Although communication of risks and benefits by service
providers can influence health-seeking behaviour [2], cur-
rent approaches to health communication do not always
achieve the expected results. Efforts frequently produce an
increase in knowledge without a corresponding change in
attitudes or behaviour[3]. This is at least partly because
conventional risk communication presumes to inform an
uninformed public and to reduce irrational thinking.
Questioning the value of these conventional one-way
knowledge transfer (KT) initiatives, more holistic perspec-
tives take account of social and cultural influences[4].
Impact studies of communication strategies to increase
vaccination in the USA, Russia and Mozambique all high-
light the need of multi-channel targeting of multiple
groups – families, communities, health practitioners and
opinion makers, such as community and religious lead-
ers[5-7].
Current devolution reforms in Pakistan are expected to
make service delivery more effective and to support insti-
tutionalised participation of community members[8,9].
Service delivery is now a district function, yet the prov-
inces are still responsible for planning and monitoring
health services [9]. The expanded programme of immuni-
sation (EPI) remains a federal responsibility. The 2002
Pakistan Integrated Household Survey claimed an
increase in immunisation coverage, mostly in the urban
areas. The proportion of fully immunised children aged
12–23 months rose from 49% to 53%, and even this small
gain was not consistent countrywide. In Balochistan,
where the project will be located, immunisation coverage
fell from 34% in 1998–9 to 24% in 2000–1, mostly attrib-
uted to diversion of resources to the polio eradication
campaigns[10].
Balochistan is Pakistan's largest province (347,000 km2)
and has the lowest population density (6.5 million, 19/
km2). It covers more than 40% of the land area, but has
less than 5% of the national population. The disease bur-
den in Pakistan is still largely poverty-related, much of it
preventable by immunisation[11,12].
Lasbella, in the south of Balochistan is one of the prov-
ince's poorest districts. In 2003 there were around 50,000
women of childbearing age in this district. There were
11,594 infants under the age of one year, and reflecting
the very high infant mortality, 8,140 children aged 12–23
months. The new district administration employs 39 full
time vaccinators, but still only achieves symbolic cover-
age. The problem does not appear to be one of supervi-
sion or management. The vaccinators report to a
superintendent, who in turn reports to the Deputy District
Health Officer, who reports to the Executive District
Officer for Health.
Statement of the research issue and approach
We believe that health care consumers make rational deci-
sions from a cost-benefit perspective[13,14]. Based on
their own knowledge, mothers and guardians weigh up
the costs and the benefits of immunisation: how much
time will it take, how much will it cost, will it work, will
there be side effects and what will happen if I do not go.
We propose that immunisation uptake is largely deter-
mined by this cost-benefit equation.
But the rationality of such decisions is a "bounded ration-
ality" [15]. This concept enables health planners to see
such factors as social norms and attitudes not as obstacles
to rationality but rather mechanisms that facilitate fast
and accurate decisions, and more efficient learning. In
addition, the weigh-up of risks may be sharply discounted
between the time of the immunization and the time of
possible infection. Also, gender and poverty probably
affect the household cost-benefit equation. The poor, who
typically have less access to services and less information
about services, almost certainly weigh up the costs and
benefits in a different way than do the rich [16]. Diseases
like measles and pertussis may be an inconvenience for
the well-nourished, whereas for the malnourished, they
can be a question of life or death. Costs of not vaccinating
(disease burden, care and funerals) are borne dispropor-
tionately by the poor; in a single epidemic, these diseases
can destroy a household economy[17].
The household cost-benefit equation is, therefore, a lens 
through which to view immunisation and the obstacles to 
immunisation
A focus on these equations gives value to the way ordinary
people see immunisation, allowing their views to be taken
systematically into account. It gives primacy to householdBMC Public Health 2005, 5:72 http://www.biomedcentral.com/1471-2458/5/72
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decisions, and recognises that communication about
immunisation is a two-way street. We propose to test the
importance of this household cost-benefit equation that
decision-makers for children derive from their knowl-
edge, attitudes, social norms, intentions, sense of agency
and degree of socialisation about immunisation.
The hypothesis is that this dynamic equation can be influ-
enced by two-way knowledge translation (KT), and based
on this culture-appropriate exchange, that people will
adjust their household cost-benefit equations and their
uptake of immunisation. A corollary of the household
cost-benefit equation is accessible to planners and health
service managers: cost-gains. Derived from the same data
used by communities for their cost-benefit equations,
cost-gains offers a common language for interaction
between health services and communities. If local health
managers understand how primary decision makers assess
immunisation – their cost-benefit equations – this can
improve their engagement with communities and lead, in
turn, to sustainable UCI.
Methods
Objective 1. Identify the barriers and information 
imbalances that reduce childhood immunisation, in 
particular increasing understanding of the household cost-
benefit equations underlying uptake of immunisation
Randomised controlled cluster trials are fairly widely used
in developed countries, and have been introduced in sev-
eral developing countries[18-20].
Randomisation
From the latest Pakistan census, 32 enumeration areas
were randomly selected to represent the population of
Lasbela district. Once the baseline survey was completed,
clusters were randomised into intervention and control,
with precautions about the usual biases of this design[21].
In each cluster, interviewers contacted homes of 100 chil-
dren under the age of 24 months of age (a total of 3344
households). Three successive cycles that examine succes-
sive cohorts of children in this age group, and the same
number of households in each site (not necessarily the
same households) will preserve the proportional repre-
sentation.
Design of survey instruments
Questionnaires were adapted from international EPI
standards. Additional fact-finding tools will produce
qualitative evidence – key informant interviews, service
worker questionnaires, protocols for institutional reviews
and focus group discussions. The results of each round
might identify additional stakeholder-driven issues and
priorities and be used to refocus the subsequent survey
cycles.
Survey content
In addition to baseline data about the coverage with and
obstacles to immunisation, we enriched the standard KAP
approach[22] with a behaviour change model adapted by
CIET to measure youth responses to risk. The beyond-KAP
approach, "cascada", refers to conscious knowledge about
immunisation and its side effects, attitudes to childhood
immunisation, social norms (what neighbours do) and
positive or negative deviation from those norms, inten-
tions to change or to vaccinate in the future, agency
(expectancy of self-efficacy or collective efficacy) and dis-
cussion about immunisation, its benefits and side effects.
The outcome of this "cascada" is the action, immunisa-
tion. We will document perceived and real costs of immu-
nisation and non-immunisation, and the household
weigh up of costs and benefits.
Piloting
Eight rounds of piloting in non-sample sites included test-
ing new sections of the instrument, testing the instrument
for flow, and then testing the instrument as a whole in
order to finalise the process. The pilot exercises assisted in
refining the instruments, testing for clarity and ensuring
proper translation.
Ethical review
Two review panels, one at the University of Ottawa and a
panel in the south of Pakistan registered with the US Gov-
ernment's Office of Human Research Protections, deliber-
ated the ethical issues and approved the study.
Objective 2. Formulate and implement knowledge transfer 
based on household cost-benefit equations, compared 
with health information in reference (control) 
communities
Intervention
We will update and translate available knowledge on
immunisation and combine this with data from the base-
line as an intervention focussed on the household cost-
benefit equation. Mass media channels can increase
awareness and knowledge, but interpersonal channels
seem to work better in changing attitudes and behav-
iour[23,24]. A combination of communication channels
could, therefore, include mass media appeals, reminder
systems and engagement through trusted sources, and
addressing risks and benefits of vaccination in an under-
standable manner[25-28]. Upon consideration of the evi-
dence, people will hopefully adjust their household cost-
benefit equations. We will measure this adjustment in the
subsequent cycles.
Analysis
We will estimate the impact of this knowledge transfer on
changing beliefs and practices of decision-makers for chil-
dren and, as a consequence, immunisation uptake. Differ-BMC Public Health 2005, 5:72 http://www.biomedcentral.com/1471-2458/5/72
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ences between intervention and reference sites will be
analysed for independence from age, sex, household
employment, community size, remoteness and other fac-
tors. Risk analysis will rely on the Mantel-Haenszel proce-
dure and contrasts reported as the odds ratio (OR) or risk
difference (RD)[29-31]. In the analysis, each site or cluster
is treated as a mini-universe characterised by certain social
dynamics, history, culture and collective practices.
Because qualitative data are coterminous (they coincide
with the same population) with the individual question-
naires it is easy to link quantitative and qualitative
data[32]. An unconditional logistic regression model will
be developed where appropriate, using a step-down
approach from a saturated model[33].
We also seek to express a planning-appropriate perspec-
tive that fits the household cost-benefit perspective. 'Gain'
is the theoretical proportion of the entire population that
stands to benefit from the removal of an obstacle or the
universalisation of an intervention. It is calculated by
multiplying the risk difference (risk among exposed
minus risk among unexposed) by the proportion requir-
ing intervention (those exposed, if the interest is to
remove risk factors).
Objective 3. Measure the impact of the KT on coverage 
and attitudes about immunisation
Focus groups to identify strategies
After the preliminary analysis, field teams will return to
the communities to hold gender stratified focus groups.
Key findings from the household interviews will be shared
with the groups to generate additional insights, including
how best to let similar communities know about the find-
ings. Focus groups typically involve 8–12 participants. In
a quiet location, groups are limited to a maximum of one
hour in recognition of the value of participants' time. Par-
ticipants are reassured about confidentiality (no identifi-
ers are recorded). A trained facilitator runs the group,
prompts to provoke discussion, and encourages partici-
pants to express opinions. A second member of the team
records the content and manages the time.
Communications
Communication strategies (see below) to share the out-
comes of the measurement with stakeholders in the inter-
vention communities will be heavily conditioned by the
outcome of the focus groups. The core concept is to social-
ise the household cost-benefit equation. Strategies are
likely to include work with local elected representatives,
community and religious leaders, service workers and
community action groups such as citizen community
boards (CCBs)[34].
Repeat survey
Each year for three years, the measurement will be
repeated in both intervention and control sites. Much of
the key instrument content will be unchanged, to detect
time trends. Responses will provide substrate for the next
round of household cost-benefit equations and cost-gain
analysis, which in turn will feed into the next round of
intervention.
Objective 4. Develop an evidence-based and gendered 
systems approach to increasing equity in 
immunisation, rooted in community knowledge, capable 
of building on local health protection cultures and of 
informing evidence-based decision-making to improve the 
health of populations and strengthen health systems 
through immunisation services
A lot of effort has gone into the supply side of immunisa-
tion (vaccine purchase, training health workers and logis-
tics). There is a need to focus systematically on the demand
for immunisation – which is probably a direct function of
the quality of information people have.
Parallel to the community-based knowledge transfer
intervention, the team will work with the district authori-
ties in Lasbela. We will build capacity to improve immu-
nisation rates in the selected district, reaching health care
workers, community leaders and policy makers. Research
teams will be trained in community-based research,
enhancing the capacity for ongoing monitoring of immu-
nisation and other key public services.
The cost-gains approach offers a bridge between planner
and community views. Proving the value of this parameter
could support a paradigm shift in resource allocation,
from a system based on reconciliation of competing sec-
toral claims without a comparable evidence base to cost-
gain planning.
The main selling point of a new knowledge transfer
approach to sustainable immunisation is that it must
work. immunisation coverage must increase measurably
and people in key positions must know about this. Main-
streaming the household cost-benefit equation begins
with respectful dialogue with local health and political
authorities about immunisation concepts, service deliv-
ery, effects and side effects in the communities. The cen-
tral activity is then to demonstrate by measuring and
communicating, in reiterative cycles, the effect on cost and
benefit assessments. Comparisons between sites with dif-
ferent levels or types of intervention will be almost as
informative as the longitudinal picture emerging by fol-
lowing each site over four years. Evaluation is thus built
into the project.BMC Public Health 2005, 5:72 http://www.biomedcentral.com/1471-2458/5/72
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In addition to the overall concept of evidence-based
immunisation support, and the household cost-benefit
equation, relevant procedures and tools include:
1. Protocols for the survey (household beyond-KAP, key
informants and institutional review) and sample selec-
tion, processing results through double data entry, epide-
miological analysis and interpretation in community-
based focus groups;
2. Procedures for achieving policy level buy-in, including
aggregation tools (like customised epidemiological map-
ping freeware) that allow compounding of local experi-
ences into regional and national pictures; a menu of
methods and practical examples of communication tools
for opening evidence-based dialogue that can increase
community ownership of immunisation.
Discussion
Engagement of communities in evidence-based planning
is a novel approach to immunisation, an intervention
driven perhaps more than any other by an inappropriate
if well-intentioned ethos of "we know what is good for
you". The idea of a household cost-benefit equation is
common sense: people weigh things up before their
health choices. This study hopes to answer questions
about what it takes to enter a dialogue that influences
these equations. The year-to-year shift in knowledge, atti-
tudes, subjective norms, intention, sense of agency, ability
to discuss, and ultimately, uptake of immunisation will be
evident from the results of the successive cycles.
Best practice cases – communities that increase immuni-
sation – will be identified and held up as positive exam-
ples of what is possible under prevailing conditions. The
direct beneficiaries will be the public, but indirect benefi-
ciaries will be planners and policy-makers in federal, pro-
vincial and district governments. Improved
understanding of immunisation risks and cost implica-
tions of higher immunisation uptake may be applicable in
many other countries. Proof of cost-gains as the planners'
corollary of the household cost-benefit equation could
open new horizons for evidence-based service-public
interaction.
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